St. Louis researchers are participating in a larger study of children and young adults with recurrent brain tumors.  The trial will test a promising type of immunotherapy using Natural Killer -- or N-K cells -- a type of immune cell that can recognize and kill cancer cells while sparing healthy cells.
The research is being supported by a two-million-dollar grant from CureSearch for Children’s Cancer
KMOX's Megan Lynch gets mre from Dr. Mohamed Abdelbaki Associate Professor of Pediatrics at Washington University School of Medicine in St. Louis, Missouri. He also serves as the Director of both the Pediatric Neuro Oncology Program and the Clinical Research Office (CRO) for the Pediatric Hematology, Oncology and Bone Marrow Transplant Division at St. Louis Children's Hospital.

St. Louis researchers are participating in a larger study of children and young adults with recurrent brain tumors.  The trial will test a promising type of immunotherapy using Natural Killer -- or N-K cells -- a type of immune cell that can recognize and kill cancer cells while sparing healthy cells. The research is being supported by a two-million-dollar grant from CureSearch for Children’s Cancer KMOX's Megan Lynch gets mre from Dr. Mohamed Abdelbaki Associate Professor of Pediatrics at Washington University School of Medicine in St. Louis, Missouri. He also serves as the Director of both the Pediatric Neuro Oncology Program and the Clinical Research Office (CRO) for the Pediatric Hematology, Oncology and Bone Marrow Transplant Division at St. Louis Children's Hospital.

With up-to-the-minute news, information, traffic and weather together and
sports reports.

With up-to-the-minute news, information, traffic and weather together and sports reports.

Advertisement